Hospira, Inc. recalled 49,620 vials of Epinephrine Injection on August 4, 2025. The recall follows concerns about the lack of assurance of sterility. Consumers should stop using the product immediately.
Lack of Assurance of Sterility.
Consumers and healthcare providers should stop using this product immediately. Contact PFIZER INC or your healthcare provider for guidance. Notification method: Letter
The recalled product is Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL). It was distributed by Hospira, Inc. and is identified by NDC 0409-4933-05.
The recall stems from a lack of assurance of sterility. This poses a high risk of infection and serious health complications for users.
No specific incidents or injuries have been reported at this time. The risk remains high due to the potential for contamination.
Stop using the product immediately. Contact Pfizer Inc. or your healthcare provider for guidance on returning the product.
For more information, visit the FDA recall page or contact Pfizer Inc. directly for assistance and guidance.
Abiomed issued a recall for 10,153 Automated Impella Controllers on October 1, 2025. The devices face potential cybersecurity vulnerabilities related to their operating system. Healthcare providers and patients should stop using these devices immediately.
Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.
AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.